ARTICLE | Clinical News
Seretide inhaled steroid/long-acting beta 2 agonist regulatory update
January 27, 2003 8:00 AM UTC
The EMEA's Committee for Proprietary Medicinal Products (CPMP) recommended approval of Seretide to treat chronic obstructive pulmonary disease. GSK plans to launch the product in the first half of the...